LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.45 | 84.90 | 5644 | 8254 | 0.6837 | 0.8881 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.45 | 84.90 | 5669 | 8254 | 0.6868 | 0.8894 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.45 | 84.90 | 656 | 8254 | 0.0795 | 0.3630 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.45 | 84.90 | 5226 | 8254 | 0.6331 | 0.8662 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 86.16 | 84.90 | 4660 | 8141 | 0.5723 | 0.8375 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 86.16 | 84.90 | 4682 | 8141 | 0.5751 | 0.8388 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 86.16 | 84.90 | 5830 | 8141 | 0.7160 | 0.9011 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 86.16 | 84.90 | 5849 | 8141 | 0.7184 | 0.9020 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 86.16 | 84.90 | 629 | 8141 | 0.0773 | 0.3555 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 86.16 | 84.90 | 5322 | 8141 | 0.6537 | 0.8749 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 84.90 | 4835 | 7680 | 0.6295 | 0.8625 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 84.90 | 4888 | 7680 | 0.6364 | 0.8657 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 84.90 | 5980 | 7680 | 0.7786 | 0.9245 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 84.90 | 6001 | 7680 | 0.7813 | 0.9255 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 84.90 | 590 | 7680 | 0.0768 | 0.3476 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 84.90 | 5557 | 7680 | 0.7235 | 0.9029 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 89.57 | 84.90 | 4983 | 7494 | 0.6649 | 0.8776 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 89.57 | 84.90 | 5018 | 7494 | 0.6696 | 0.8797 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 89.57 | 84.90 | 6094 | 7494 | 0.8131 | 0.9370 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 89.57 | 84.90 | 6116 | 7494 | 0.8161 | 0.9381 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 89.57 | 84.90 | 469 | 7494 | 0.0626 | 0.3027 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 89.57 | 84.90 | 5683 | 7494 | 0.7583 | 0.9162 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 91.27 | 84.90 | 5094 | 7420 | 0.6865 | 0.8867 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 91.27 | 84.90 | 5137 | 7420 | 0.6923 | 0.8892 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 91.27 | 84.90 | 6258 | 7420 | 0.8434 | 0.9479 | MN20160318_Q02 | J05 |